Skip to contentLees-Rolfe Garth — Inhibikase Therapeutics, Inc. insider: 8 transactions · InsiderLensInsider trading activity of Lees-Rolfe Garth
- Transactions on record
- 8
- since Apr 2, 2024
- Open-market buys
- 0
- Open-market sells
- 0
- Companies traded
- 1
- last filing Jan 22, 2025
Figures computed from official regulatory filings — methodology.
Companies where Lees-Rolfe Garth has traded
Track record of Lees-Rolfe Garth
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Lees-Rolfe Garth
Co-insiders of Lees-Rolfe Garth
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
GRINT PAUL CInhibikase Therapeutics, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 22, 2025 | OtherD | -5,834 | 0.00 USD | $0 | SEC |
| Jan 22, 2025 | AwardD | 5,834 | 0.00 USD | $0 | SEC |
| Jan 22, 2025 | OtherD | -90,000 | 0.00 USD | $0 | SEC |
| Jan 22, 2025 | AwardD | 90,000 | 0.00 USD | $0 | SEC |
| Jan 7, 2025 | AwardD | 235,383 | 0.00 USD | $0 | SEC |
| Jan 7, 2025 | AwardD | 470,861 | 0.00 USD | $0 | SEC |
| Jan 7, 2025 | AwardD | 432,853 | 0.00 USD | $0 | SEC |
| Apr 2, 2024 | AwardD | 90,000 | 0.00 USD | $0 | SEC |